| 2024-06-24 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 899 0.0008% | $155.66 | $139,938 | -5.13% | |
| 2024-06-17 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 916 0.0008% | $159.04 | $145,678 | -2.41% | |
| 2024-02-29 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 397 0.0004% | $167.08 | $66,331 | -5.45% | |
| 2023-07-03 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 472 0.0004% | $179.55 | $84,747 | -3.85% | |
| 2023-06-23 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 840 0.0008% | $182.85 | $153,594 | -2.74% | |
| 2023-06-20 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 190 0.0002% | $192.54 | $36,583 | -8.79% | |
| 2023-03-01 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 343 0.0003% | $240.21 | $82,392 | -18.38% | |
| 2022-07-01 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 317 0.0003% | $158.50 | $50,245 | +23.83% | |
| 2022-06-17 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 161 0.0002% | $136.64 | $21,999 | +56.46% | |
| 2021-07-01 | Sale | BeiGene, Ltd. BGNE | Chief Financial Officer | 308 0.0003% | $349.06 | $107,512 | -26.31% |